FR Imrie, AD Dick - Current Opinion in Ophthalmology, 2007 - journals.lww.com Purpose of review This review summarizes current nonsteroidal drug therapies for
noninfectious posterior and intermediate uveitis. Recent findings Continuing
evidence shows that second-line agents including antimetabolites, T-cell ... Cited by 9 - Related articles - BL Direct - All 2 versions
S Sugita - British Journal of Ophthalmology, 2007 - bjo.bmj.com Corticosteroids and second-line immunosuppressive agents such as cyclosporin and
tacrolimus (FK506) can effectively control intraocular inflammation in patients
with uveitis 1 (see page 237). Intraocular inflammation in uveitis causes ... Cited by 1 - Related articles - BL Direct - All 4 versions
L Kowalczuk, E Touchard, S Camelo, MC Naud … - Investigative Ophthalmology & Visual Science, 2009 - ARVO 1 From the INSERM UMRS 872 Team17, Centre de Recherches des Cordeliers,
Université Pierre et Marie Curie, Université Paris Descartes, Paris, France; 2
INSERM IFR65/U515, Saint Antoine Hospital, Paris, France; 3 INSERM U640, ... Cited by 1 - Related articles - All 2 versions
MA Cunningham, BA Austin, Z Li, B Liu, S Yeh … - Investigative Ophthalmology & Visual Science, 2009 - ARVO RESULTS. Voclosporin prevented EAU development in rats receiving medium and high
preventive doses, whereas high-dose voclosporin administration effectively
treated EAU. Lymphocytes from animals treated with voclosporin had ... Cited by 1 - Related articles - All 3 versions
T Watanabe, H Keino, Y Sato, A Kudo, H … - Investigative Ophthalmology & Visual Science, 2009 - ARVO RESULTS. The level of HMGB-1 in aqueous humor was significantly elevated in eyes
with EAU, and HMGB-1 and tumor necrosis factor (TNF)- levels correlated with
active ocular inflammation. HMGB-1 was expressed in the iris, ciliary body, ... Related articles - All 3 versions
S Wadhwa, R Paliwal, SR Paliwal, SP Vyas - Current Pharmaceutical Design, 2009 - ingentaconnect.com Abstract: Controlled drug delivery to eye is one of the most challenging fields
of pharmaceutical research. Low drug- contact time and poor ocular
bioavailability due to drainage of solution, tear turnover and its dilution ... Related articles - All 2 versions
RWJ Lee, LP Schewitz, LB Nicholson, CM … - Investigative Ophthalmology & Visual Science, 2009 - ARVO METHODS. Peripheral blood mononuclear cells (PBMCs) from 27 patients with
uveitis and 4 normal volunteers were cultured for 5 days with CD3-CD28 beads. In
vitro steroid refractivity or responsiveness was determined by the presence ... Related articles - All 2 versions
K Oh-i, H Keino, H Goto… - bjo.bmj.com Keiko Oh-i*, MD; Hiroshi Keino*, MD; Hiroshi Goto, MD; Naoyuki Yamakawa, PhD;
Masaru Takeuchi, MD; Masahiko Usui, MD; Takuya Iwasaki, MD. Department of
Ophthalmology, Tokyo Medical University, Tokyo, JAPAN Running Title: Up- ... Related articles
K Oh-i, H Keino, H Goto, N Yamakawa, M … - British Journal of Ophthalmology, 2007 - bjo.bmj.com Methods: Rats were immunised with interphotoreceptor retinoid binding protein
peptide (R14) and given intravitreal injection of tacrolimus on day 12 after
immunisation. As control, immunised rats received intravitreal injection of ... Related articles - BL Direct - All 3 versions